Mark For: EXCELAR™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 76209731 |
Mark Literal Elements | EXCELAR |
Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | FILE REPOSITORY (FRANCONIA) 2004-05-21 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Michael E. Whitham |
Law Office Assigned | M60 |
Employee Name | CLARK, GLENN G |
2001-02-14 | Application Filed |
2002-06-25 | Published |
2002-06-25 | Published for Opposition |
2004-03-18 | Abandon |
2004-03-18 | Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume |
2004-03-18 | Status: Dead/Abandoned |
2004-05-21 | Location: FILE REPOSITORY (FRANCONIA) |
2018-07-08 | Transaction Date |
Party: | Allos Therapeutics, Inc. |
Address | 7000 North Broadway Suite 310 Denver, COLORADO UNITED STATES 80221 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Application | IMAGE/TIFF | 2001-02-14 |
Drawing | IMAGE/TIFF | 2001-02-14 |
Paper Correspondence Incoming | 2003-02-03 | |
Change of Address | 2003-04-21 | |
Extension of Time to File SOU | 2003-09-15 | |
Paper Correspondence Incoming | IMAGE/TIFF | 2003-09-17 |
ITU Extension Approval | 2003-09-26 | |
Notice of Abandonment | 2004-05-20 | |
Paper Correspondence Incoming | 2008-07-11 | |
Paper Correspondence Incoming | 2008-10-20 | |
Notation to File | 2008-10-23 | |
Prosecutio Hist for Review Correspondenc | 2008-10-24 |
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations containing one or more compounds which allosterically modify hemoglobin to affect its oxygen carrying capacity where the compounds are dispersed or dissolved in a carrier fluid, gel, ointment or matrix where the preparations are used in a wide variety of therapies, namely, oncology, anti-neoplast treatment, blood storage, blood restoration, and are used for treating a wide variety of disorders, namely, wound healing, ischemia, hypoxia, and hypothermia
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations containing one or more compounds which allosterically modify hemoglobin to affect its oxygen carrying capacity where the compounds are dispersed or dissolved in a carrier fluid, gel, ointment or matrix where the preparations are used in a wide variety of therapies, namely, oncology, anti-neoplast treatment, blood storage, blood restoration, and are used for treating a wide variety of disorders, namely, wound healing, ischemia, hypoxia, and hypothermia |
Description | Date | Proceeding Number |
---|---|---|
REVIEW OF CORRESPONDENCE COMPLETE | 2008-10-23 | 77978 |
PAPER RECEIVED | 2008-10-20 | |
PAPER RECEIVED | 2008-07-11 | |
ABANDONMENT - NO USE STATEMENT FILED | 2004-05-20 | |
ASSIGNED TO EXAMINER | 2004-04-26 | 69191 |
SOU EXTENSION 2 GRANTED | 2003-09-25 | |
PAPER RECEIVED | 2003-09-17 | |
TEAS EXTENSION RECEIVED | 2003-09-15 | |
SOU EXTENSION 2 FILED | 2003-09-15 | |
SOU EXTENSION 1 GRANTED | 2003-05-31 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2003-04-21 | |
SOU EXTENSION 1 FILED | 2003-02-03 | |
PAPER RECEIVED | 2003-02-03 | |
NOA MAILED - SOU REQUIRED FROM APPLICANT | 2002-09-17 | |
PUBLISHED FOR OPPOSITION | 2002-06-25 | |
NOTICE OF PUBLICATION | 2002-06-05 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-12-13 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-08-13 | |
NON-FINAL ACTION MAILED | 2001-06-19 | |
ASSIGNED TO EXAMINER | 2001-06-08 | 78190 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.